期刊文献+

Profile of Implanon~ acceptors and pattern of side effects

Profile of Implanon~ acceptors and pattern of side effects
原文传递
导出
摘要 Objective To determine the social and biological characteristics of Implanon acceptors at Ibadan Nigeria, and also to describe reasons why they opt for this choice and their concerns. Methods This was a descriptive study that retrospectively reviewed all records of the Implanon acceptors from January 2006 to December 2009 at University College Hospital Ibadan, Nigeria. Results One hundred and twenty-eight women accepted Implanon as a modern contraception accounting 4.3% of the total number of clients seen (2 972) during the period. The age range of the client that accepted Implanon was 26-43 years with a mean of 33.6 ±2.4 years. Of the 128 Implanon acceptors, 101 (78.9%) had used other contraceptive methods before. The commonest reason for switching to Implanon by clients was failure of the contraceptive method that was previously used (32.7%). Within the first year follow-up of insertion, none of the Implanon acceptors had expressed desire for removal due to any of the side effects, and none contraceptive failure was observed during their follow-up evaluation. Conclusion The findings suggest that Implanon could safely be used by all women of reproductive age group including those who desire future fertility. Objective To determine the social and biological characteristics of Implanon acceptors at Ibadan Nigeria, and also to describe reasons why they opt for this choice and their concerns. Methods This was a descriptive study that retrospectively reviewed all records of the Implanon acceptors from January 2006 to December 2009 at University College Hospital Ibadan, Nigeria. Results One hundred and twenty-eight women accepted Implanon as a modern contraception accounting 4.3% of the total number of clients seen (2 972) during the period. The age range of the client that accepted Implanon was 26-43 years with a mean of 33.6 ±2.4 years. Of the 128 Implanon acceptors, 101 (78.9%) had used other contraceptive methods before. The commonest reason for switching to Implanon by clients was failure of the contraceptive method that was previously used (32.7%). Within the first year follow-up of insertion, none of the Implanon acceptors had expressed desire for removal due to any of the side effects, and none contraceptive failure was observed during their follow-up evaluation. Conclusion The findings suggest that Implanon could safely be used by all women of reproductive age group including those who desire future fertility.
出处 《Journal of Reproduction and Contraception》 CAS CSCD 2015年第1期46-52,共7页 生殖与避孕(英文版)
关键词 IMPLANON contraceptive methods hormonal contraception WOMEN ACCEPTORS NIGERIA implanon contraceptive methods hormonal contraception women acceptors Nigeria
  • 相关文献

参考文献24

  • 1Bennink HJ. The pharmacokinetics and pharmacodynamics of Implanon", a single-rod etonogestrel contra-ceptive implant. Eur J Contracept Reprod Health Care, 2000, 5(Suppl 2): 12-20.
  • 2Hohmann H, Creinin MD. The contraceptive implant. Clin Obstet Gynecol, 2007,50(4):907-17.
  • 3Ladipo OA, Akinso SA. Contraceptive implants. Afr J Reprod Health, 2005, 9(1):16-23.
  • 4Adams K, Beal MW. Implanon": a review of the literature with recommendations for clinical management. J Midwifery Womens Health, 2009, 54(2): 142-9.
  • 5Bensouda-Grimaldi L, Jonville-Bera AP, Beau-Salinas F, et al. Insertion problems, removal problems, and contraception failures with Implanon". Gynecol Obstet Fertil, 2005, 33(12):986-90.
  • 6Boucoiran I, Trastour C, Faraj L, et al. Pregnancy with Implanon": a report on three cases. Gynecol Obstet Fertil, 2011, 39(2):e52-4.
  • 7Legardy JK, Curtis KM. Progesterone-only contraceptive use among women with sickle cell anemia: a systematic review. Contraception, 2006, 73(2): 195-204.
  • 8McDonald-Mosley R, Burke AE. Contraceptive implants. Semin Reprod Med, 2010, 28(2):110-7.
  • 9Sabatini R, Cagiano R. Comparison profiles of cycle control, side effects and sexual satisfaction of three hormonal contraceptives. Contraception, 2006, 74(3):220-3.
  • 10Blumenthal PD, Gernzell-Danielsson K, Marintcheva-Petrova M. Tolerability and clinical safety of'Implanon", Eur J Contracept Reprod Health Care, 2008, 13(Suppll):29-36.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部